Compare Kinder Morgan Inc (KMI) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Recursion Pharmaceuticals Inc — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: Kinder Morgan Inc is far larger — about 47.4× Recursion Pharmaceuticals Inc's market cap, and Kinder Morgan Inc pays a 3.61% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| KMI | RXRX | |
|---|---|---|
Market Cap | $72.48B | $1.53B |
Sector | Energy | Health |
52-Week High | $34.31 | $6.79 |
52-Week Low | $25.84 | $2.84 |
Enterprise Value | $104.36B | $946.50M |
Dividend Yield | 3.61% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
